2026 Bogdan Czerniak: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	73	19582	18376	9751	8995	332	23230

Bogdan Czerniak publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bogdan Czerniak sits on this spectrum.

101 publications 1,796+

This scientist: 332 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Bogdan Czerniak D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bogdan Czerniak sits on this spectrum.

70 D-Index 217+

This scientist: 73 D-Index — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Bogdan Czerniak is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research spans a range of fields within medicine, with particular focus on surgery, pulmonary and respiratory medicine, molecular biology, oncology, and immunology.

The scientist's body of work includes a concentration on bladder and urothelial cancer treatments, urinary and genital oncology studies, epigenetics and DNA methylation, cancer immunotherapy and biomarkers, ferroptosis and cancer prognosis, sarcoma diagnosis and treatment, and urological disorders and treatments.

Key recent publications include the following:

"9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy," 2021, Nature Communications
"Assessment of Luminal and Basal Phenotypes in Bladder Cancer," 2020, Scientific Reports
"Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy," 2020, Communications Biology
"Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression," 2022, Nature Biotechnology
"MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers," 2022, Nature Communications

Czerniak frequently publishes in several journals, including:

Journal of Clinical Oncology
Human Pathology
Nature Communications
bioRxiv (Cold Spring Harbor Laboratory)
Laboratory Investigation

Frequent coauthors in their publications include:

Charles C. Guo
Colin P. Dinney
Jianjun Gao
David J. McConkey
Arlene O. Siefker-Radtke

Best Publications

The Immune Landscape of Cancer

Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

4501
Citations
Comprehensivemolecular characterization of clear cell renal cell carcinoma

Chad J. Creighton;Margaret Morgan;Preethi H. Gunaratne;Preethi H. Gunaratne;David A. Wheeler

4161
Citations
Comprehensive molecular characterization of urothelial bladder carcinoma

John N Weinstein;Rehan Akbani;Bradley McIntosh Broom;Wenyi Wang

3617
Citations
Oncogenic Signaling Pathways in The Cancer Genome Atlas

Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

3193
Citations
Pan-cancer analysis of whole genomes

Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

3090
Citations
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

2565
Citations
Comprehensive Characterization of Cancer Driver Genes and Mutations.

Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

2512
Citations
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

A. Gordon Robertson;Jaegil Kim;Hikmat Al-Ahmadie;Joaquim Bellmunt

2510
Citations
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

Woonyoung Choi;Sima Porten;Seungchan Kim;Daniel Willis

1644
Citations
Erratum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (Nature Genetics (2009) 41 (991-995))

Xifeng Wu;Yuanqing Ye;Lambertus A. Kiemeney;Patrick Sulem

1544
Citations
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

W. Marston Linehan;Paul T. Spellman;Christopher J. Ricketts;Chad J. Creighton

1295
Citations
Genomic and Functional Approaches to Understanding Cancer Aneuploidy

Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

1116
Citations
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.

Aurélie Kamoun;Aurélien de Reyniès;Yves Allory;Yves Allory;Gottfrid Sjödahl

1000
Citations
Patterns of somatic structural variation in human cancer genomes

Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

942
Citations
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma

Caleb F. Davis;Christopher J. Ricketts;Min Wang;Lixing Yang

902
Citations
Pathogenic Germline Variants in 10,389 Adult Cancers

Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

848
Citations
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53

Hiroshi Katayama;Kaori Sasai;Hidehiko Kawai;Hidehiko Kawai;Zhi Min Yuan

802
Citations
Aberrant Promoter Methylation Profile of Bladder Cancer and Its Relationship to Clinicopathological Features

Riichiroh Maruyama;Shinichi Toyooka;Kiyomi O. Toyooka;Kenichi Harada

635
Citations
Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

589
Citations
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

Nathaniel Rothman;Montserrat Garcia-Closas;Nilanjan Chatterjee;Nuria Malats

499
Citations

Frequent Co-Authors

Colin P. Dinney The University of Texas MD Anderson Cancer Center

Ashish M. Kamat The University of Texas MD Anderson Cancer Center

H. Barton Grossman The University of Texas MD Anderson Cancer Center

David J. McConkey Johns Hopkins University

Keith A. Baggerly The University of Texas MD Anderson Cancer Center

Pheroze Tamboli The University of Texas MD Anderson Cancer Center

John N. Weinstein The University of Texas MD Anderson Cancer Center

Chad J. Creighton Baylor College of Medicine

Louis L. Pisters The University of Texas MD Anderson Cancer Center

Gordon B. Mills Oregon Health & Science University

External Links

Personal website of Bogdan Czerniak

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees can offer flexible entry points into the medical field. For those seeking a rapid start, fast track lpn programs online provide an accelerated route to becoming a Licensed Practical Nurse, allowing you to enter the workforce in less time.

Registered nurses looking to advance their careers may consider bsn to np programs online, which can lead to specialized nurse practitioner roles, such as in psychiatric and mental health.

If your interests lie in healthcare leadership or management, pursuing a graduate degree in healthcare administration is a smart move. Many prospective students compare the best online mha programs to identify flexible, reputable pathways. Cost-conscious students may also search for the most affordable online mha programs to maximize value without compromising on quality.

These online degree paths offer various options suited to different career goals, whether you want to enter clinical practice quickly or step into healthcare management roles.